Skip to main content

Day: March 7, 2024

Xtract One Releases Second Quarter Fiscal 2024 Results

Strong Year-over-Year Growth; Company on Track for Record Performance TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced fiscal second quarter results for the three and six month periods ended January 31, 2024. All information is in Canadian dollars unless otherwise indicated. Second Quarter Financial HighlightsRevenue of $2.9 million for the three months ended January 31, 2024 versus $0.8 million in the same period in the prior year.Gross margin of 61.1% for the second quarter as compared to 47.1% for the same period last year.Announced several new customer wins across multiple market segments...

Continue reading

Conifex Provides Financial Update

VANCOUVER, British Columbia, March 07, 2024 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”) (TSX: CFF) announced today that it has completed a first amendment to credit agreement and accommodation agreement (the “Amendment”) with Wells Fargo Capital Finance Corporation Canada (“Wells Fargo”), pursuant to which Wells Fargo agreed, subject to certain terms and conditions, to amend Conifex’s existing lumber business credit facility (the “Facility”) and provide certain accommodations thereunder.  Following the Amendment, the Facility is secured by substantially all Conifex’s lumber business assets. Benchmark SPF lumber prices declined 50% in 20231 which resulted in negative earnings before finance costs, taxes, depreciation and amortization (“EBITDA”) in 2023...

Continue reading

Ultimovacs ASA: Mandatory notification of trade by primary insiders

Oslo, 7 March 2024: Langøya Invest AS, a closely related party of Ketil Fjerdingen, a board member and primary insider in Ultimovacs ASA, has today sold 596,006 shares in the company at an average price of NOK 9.5245 per share. Following these transactions, Langøya Invest AS and closely related parties hold 800,000 shares in Ultimovacs ASA. Watrium AS, a closely related party of Haakon Stenrød, a board member and primary insider in Ultimovacs ASA, has today sold 1,780,575 shares in the company at an average price of NOK 9.6718 per share. Following these transactions, Watrium AS and closely related parties hold 0 shares in Ultimovacs ASA. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.Attachments20240307...

Continue reading

Crew Energy Announces Fourth Quarter and Full Year 2023 Results Highlighted by Record Condensate Production and Balance Sheet Strengthening

CALGARY, Alberta, March 07, 2024 (GLOBE NEWSWIRE) — Crew Energy Inc. (TSX: CR; OTCQB: CWEGF) (“Crew” or the “Company”), a growth-oriented natural gas weighted producer operating in the world-class Montney play in northeast British Columbia (“NE BC”), is pleased to announce our operating and financial results for the three and twelve-month periods ended December 31, 2023. Crew’s audited consolidated Financial Statements and Notes, Management’s Discussion and Analysis (“MD&A”) and Annual Information Form are available on Crew’s website and filed on SEDAR+ at sedarplus.ca. HIGHLIGHTS30,178 boe per day1 (181 mmcfe per day) average production in 2023, while Q4/23 production averaged 30,928 boe per day1 (186 mmcfe per day) and was 15% higher than the preceding quarter. Crew’s Q4/23 volumes by product averaged:6,268...

Continue reading

Total Energy Services Inc. Announces Q4 2023 Results

CALGARY, Alberta, March 07, 2024 (GLOBE NEWSWIRE) — Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months and year ended December 31, 2023. Financial Highlights ($000’s except per share data)  Three months endedDecember 31   Year endedDecember 31    2023     2022 Change       2023   2022 Change  Revenue $ 213,758   $ 211,479 1 %   $ 892,396 $ 759,813 17 %Operating income   23,510     15,605 51 %     84,622   49,343 71 %EBITDA(1)   45,276     35,872 26 %     168,961   131,320 29 %Cashflow   44,457     38,590 15 %     163,321   130,795 25 %Net income (loss)   (7,861 )   12,264 nm     41,594   37,999 9 %Attributable to shareholders   (7,847 )   12,244 nm     41,625   38,008 10 %                       Per Share Data (Diluted)                      EBITDA(1) $ 1.11   $ 0.84 32 %   $ 4.11 $ 3.06 34 %Cashflow $ 1.09   $ 0.91 20 %   $ 3.97 $ 3.04 31 %                       Attributable...

Continue reading

Swiss Water Decaffeinated Coffee Inc. Conference Call Notification for 2023 Fourth Quarter Results

VANCOUVER, British Columbia, March 07, 2024 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX: SWP) (“Swiss Water” or “the Company”) announced today that it will hold a conference call to discuss its financial results for the three months and year ended December 31, 2023, on Thursday, March 14, 2024, at 1:00 PM Pacific (4:00 pm Eastern). The call can be accessed by dialing, approximately five minutes before the call:1-888-506-0062 (toll-free) or 1-973-528-0011 (international); participant access code 200437The listener will be prompted to provide the Company name. A replay will be available through March 28, 2024, at1-877-481-4010 (toll-free) or 1-919-882-2331 (international); replay passcode 50035The financial results will be released on Wednesday, March 13, 2024, after the market closes. About...

Continue reading

Lavoro Reports Fiscal Second Quarter 2024 Earnings Results

Lavoro’s revenue for 2Q24 reached $618.7 million*, marking a 1% increase compared to the prior year period, as volume growth led by market share gains helped to offset continued significant input price deflationary pressures in crop protection and fertilizers across various operating regions 2Q24 gross profit stood at $103.0 million, reflecting a -17% decrease year-over-year, with gross margins contracting by -360 basis points to 16.7%, driven mainly by deflationary pressures affecting Ag retail distribution margins, partly mitigated by a more favorable segment mix, as Crop Care grew to represent 24% of Lavoro’s gross profit in 2Q24 (up from 16% in 2Q23) Crop Care segment emerged as a highlight this quarter, with revenue increasing 26% to $72.8 million, and gross profit expanding 21% to $25.7 million driven by strong growth in specialty...

Continue reading

Ring Energy Announces Record Fourth Quarter and Full Year 2023 Results, Year-End 2023 Proved Reserves and Additional 2024 Guidance

THE WOODLANDS, Texas, March 07, 2024 (GLOBE NEWSWIRE) — Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported record operational and financial results for the fourth quarter and full year 2023, year-end 2023 proved reserves and provided additional 2024 operational and financial guidance. 2023 Q4 and Full Year Highlights and Recent Key ItemsGrew fourth quarter total sales volumes 11% to a record 19,397 barrels of oil equivalent per day (“Boe/d”) from the third quarter;Increased fourth quarter oil sales volumes 13% to a record 13,637 barrels of oil per day (“Bo/d”) from the third quarter;Increased year-over-year total sales volumes by 47% to a record 18,119 Boe/d;Grew full year oil sales volumes by 32% to a record 12,548 Bo/d from 2022;Reported net income of $50.9 million, or $0.26 per diluted...

Continue reading

Team, Inc. Reports Fourth Quarter and Full Year 2023 Results

SUGAR LAND, Texas, March 07, 2024 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global, leading provider of specialty industrial services offering clients access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights1:Announced fourth quarter 2023 revenues of $214.1 million, up 1.3% over the 2022 fourth quarter revenue of $211.3 million. Reported fourth quarter 2023 net loss of $23.1 million, a $33.8 million improvement from the 2022 fourth quarter net loss of $56.9 million. Improved consolidated Adjusted EBITDA2 to $9.7 million (4.5% of consolidated revenue), an increase of 45.1% from $6.7 million (3.2% of consolidated...

Continue reading

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business UpdateAdvanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 through 3 years old) and children (4 through 7 years old) Strengthened executive leadership team in preparation for BLA submission Reported cash and cash equivalents of $141 millionDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today reported financial results for the full year 2023. The audit procedures have been substantially completed by the Company’s statutory auditors and financials – prepared under both US GAAP and IFRS for the purpose...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.